<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00846040</url>
  </required_header>
  <id_info>
    <org_study_id>090081</org_study_id>
    <secondary_id>09-DK-0081</secondary_id>
    <nct_id>NCT00846040</nct_id>
  </id_info>
  <brief_title>Reduced Carbohydrate Versus Fat in Obese Subjects</brief_title>
  <official_title>Selective Reduction of Dietary Carbohydrate Versus Fat: Effects on Metabolism, Endocrine Physiology, Brain Activity and Reward Circuitry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Popular weight loss strategies often involve reducing an individual's consumption of&#xD;
      carbohydrates or fat. However, no controlled study has been carried out to evaluate the&#xD;
      effects of reducing carbohydrate versus fat consumption while keeping the other nutrients at&#xD;
      standard levels to maintain an individual's weight. Researchers are interested in&#xD;
      investigating how different restrictions of carbohydrates or fats affect the many processes&#xD;
      involved in weight loss, including brain activity and blood and brain chemical composition.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Popular weight loss strategies often prescribe a targeted reduction of dietary carbohydrate&#xD;
      or fat. But surprisingly, no controlled human feeding study has ever investigated the effects&#xD;
      of a selective reduction of dietary carbohydrate versus fat while keeping the other dietary&#xD;
      macronutrients at their baseline weight-maintenance values. The present study was designed to&#xD;
      address this knowledge gap and improve our understanding of how selective reduction of&#xD;
      dietary fat versus carbohydrate may differentially impact the many feedback control processes&#xD;
      that act to resist weight loss.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
      - To determine the comparative effects of two controlled fat- or carbohydrate-restricted&#xD;
      diets and an outpatient weight loss program on blood and brain chemical composition, weight&#xD;
      loss (fat and lean body mass), and regional brain activity in lean and obese individuals.&#xD;
&#xD;
      Eligibility:&#xD;
&#xD;
      - Healthy individuals between 18 and 45 years of age who are either lean (body mass index&#xD;
      between 18.5 kg/m(2) and 25 kg/m(2)) or obese (body mass index above 30.0 kg/m(2), weight&#xD;
      less than 350 pounds) and are right-handed.&#xD;
&#xD;
      Design:&#xD;
&#xD;
        -  Lean participants: Participants will be screened with a medical history, physical&#xD;
           examination, blood and urine tests, and weight maintenance observations (food diaries&#xD;
           and physical activity monitors). For the scanning visit, participants will receive&#xD;
           balanced meals from the National Institutes of Health to consume for 2 days before the&#xD;
           visit. During the scanning visit, participants will continue to eat the weight&#xD;
           maintenance diet, complete questionnaires, and have a series of imaging studies&#xD;
           (including positron emission tomography and magnetic resonance imaging tests) to&#xD;
           evaluate brain response to food and other stimuli.&#xD;
&#xD;
        -  Obese participants: Participants will be screened with a medical history, physical&#xD;
           examination, blood and urine tests, and weight maintenance observations (food diaries&#xD;
           and physical activity monitors). During the first inpatient visit, obese participants&#xD;
           will eat a weight-maintenance diet for 5 days to establish baseline measurements. After&#xD;
           several days of eating a weight-maintenance diet, 20 obese adult volunteers (BMI above&#xD;
           30 kg/m2) will be admitted to the metabolic clinical research unit (MCRU) and, after 5&#xD;
           additional days of the baseline diet, their diets will be modified to result in either&#xD;
           85% reduction of the baseline dietary fat or a 60% reduction of the baseline dietary&#xD;
           carbohydrate for the next 6 days. These diet modifications produce an equivalent caloric&#xD;
           reduction. The primary outcome measurements will be changes of metabolism, brain reward&#xD;
           circuitry and regional brain activity in response to food stimuli measured during the&#xD;
           baseline and reduced calorie diet phases. Immediately following each controlled diet, we&#xD;
           will measure 3 days of ad-libitum food intake using a computerized vending machine&#xD;
           system. The subjects will return to the MCRU after a 2-10 week washout period to receive&#xD;
           the opposite reduced calorie diet. Twenty control subjects with normal body weight (BMI&#xD;
           between 18.5 - 25 kg/m2) will have measurements of brain reward circuitry and regional&#xD;
           brain activity in response to food stimuli while on a balanced, weight-maintenance diet.&#xD;
           Immediately following the second in-patient visit, all of the obese subjects will be&#xD;
           assigned to a 12 week out-patient weight loss program with the goal of achieving at&#xD;
           least 5% weight loss. We will investigate the relationship between short-term fat&#xD;
           imbalances measured during the in-patient phases, and the body weight and fat changes&#xD;
           during the weight loss program. We will evaluate the effects of weight loss on&#xD;
           metabolism, brain reward circuitry, and regional brain activity in response to food&#xD;
           stimuli. Finally, if the subjects are available for long-term follow-up, then we will&#xD;
           investigate their metabolic phenotype, brain reward circuitry, and regional brain&#xD;
           activity in response to food stimuli yearly over the subsequent 5 years following the&#xD;
           weight loss intervention. This study will result in an improved understanding of the&#xD;
           physiological mechanisms that sense and respond to negative energy balance acutely,&#xD;
           after several weeks, and after several years, and may eventually lead to increased&#xD;
           long-term success of obesity treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 13, 2009</start_date>
  <completion_date type="Actual">October 20, 2014</completion_date>
  <primary_completion_date type="Actual">February 24, 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Respiratory Quotient (RQ)</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Respiratory quotient was calculated as the ratio of carbon dioxide production to oxygen consumption as measured in a metabolic chamber for at least 23 continuous hours on days 2 and 5 of the baseline diet and days 1, 4, and 6 of the reduced-energy diets.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in 24 Hour Energy Expenditure</measure>
    <time_frame>Baseline and 14 days</time_frame>
    <description>24 hour energy expenditure was measured in a respiratory chamber.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cumulative Fat Imbalance</measure>
    <time_frame>Baseline and 14 days</time_frame>
    <description>Measured as the difference between dietary fat intake and fat oxidation by the body as measured in the respiratory chamber</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caudate Dopamine D2-like Receptor Binding Potential (D2BP)</measure>
    <time_frame>Day 2 of in-patient admission</time_frame>
    <description>The time-activity curves for [18F]fallypride tracer concentration in the ROIs were measured by PET and kinetic parameters were fit to a four compartment mathematical model (with the cerebellum used as the reference tissue). D2BP was expressed as the dimensionless ratio of rate constants quantifying binding and unbinding of tracer in the regions of interest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Putamen Dopamine D2-like Receptor Binding Potential (D2BP)</measure>
    <time_frame>Day 2 of in-patient admission</time_frame>
    <description>The time-activity curves for [18F]fallypride tracer concentration in the ROIs were measured by PET and kinetic parameters were fit to a four compartment mathematical model (with the cerebellum used as the reference tissue). D2BP was expressed as the dimensionless ratio of rate constants quantifying binding and unbinding of tracer in the regions of interest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accumbens Dopamine D2-like Receptor Binding Potential (D2BP)</measure>
    <time_frame>Day 2 of in-patient admission</time_frame>
    <description>The time-activity curves for [18F]fallypride tracer concentration in the ROIs were measured by PET and kinetic parameters were fit to a four compartment mathematical model (with the cerebellum used as the reference tissue). D2BP was expressed as the dimensionless ratio of rate constants quantifying binding and unbinding of tracer in the regions of interest.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Obese RF then RC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Obese adult volunteers (BMI above 30 kg/m2) randomized to receive an 85% reduction of baseline dietary fat (RF) for 2 weeks. After a washout period of 2 weeks, they then received a 60% reduction of baseline dietary carbohydrate (RC) for 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese RC then RF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Obese adult volunteers (BMI above 30 kg/m2) randomized to receive a 60% reduction of baseline dietary carbohydrate (RC) for 2 weeks. After a washout period of 2 weeks, they then received an 85% reduction of baseline dietary fat (RF) for 2 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lean Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lean adult volunteers (BMI below 30kg/m2) placed on a weight-maintenance diet using a standard diet composition of 50% carbohydrate, 35% fat, and 15% protein on an out-patient basis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Reduced fat diet</intervention_name>
    <description>RF (selective reduction of 85% of baseline fat calories per day)</description>
    <arm_group_label>Obese RC then RF</arm_group_label>
    <arm_group_label>Obese RF then RC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Reduced carbohydrate diet</intervention_name>
    <description>RC (selective reduction of 60% of baseline carbohydrate calories per day)</description>
    <arm_group_label>Obese RC then RF</arm_group_label>
    <arm_group_label>Obese RF then RC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Drug: f-18 fallypride</intervention_name>
    <description>Dopamine D2 receptor availability is measured by positron emission tomography (PET) using the positron emitting compound [18F] fallypride which binds competitively with dopamine to the D2 receptor.</description>
    <arm_group_label>Lean Control</arm_group_label>
    <arm_group_label>Obese RC then RF</arm_group_label>
    <arm_group_label>Obese RF then RC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <description>Functional MRI (fMRI) will be used to measure the effects of diet and weight loss on regional brain activity</description>
    <arm_group_label>Lean Control</arm_group_label>
    <arm_group_label>Obese RC then RF</arm_group_label>
    <arm_group_label>Obese RF then RC</arm_group_label>
    <other_name>Functional MRI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PET</intervention_name>
    <description>Positron emission tomography (PET) will be used to assess whether To assess whether brain activity and reward pathways are altered</description>
    <arm_group_label>Lean Control</arm_group_label>
    <arm_group_label>Obese RC then RF</arm_group_label>
    <arm_group_label>Obese RF then RC</arm_group_label>
    <other_name>Positron emission tomography</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
          -  Age 18-45 years, male or female&#xD;
&#xD;
          -  Body mass less than 350 lbs. (max. weight dictated by table limit for functional&#xD;
             magnetic resonance imaging (fMRI) scanner) when acquisition of large bore fMRI is&#xD;
             complete, max. wt. limit will increase to 400 lbs.&#xD;
&#xD;
          -  Weight stable (less than plus or minus 5 kg over past 6 months)&#xD;
&#xD;
          -  Body mass index greater than or equal to 30.0 kg/m(2)&#xD;
&#xD;
          -  Premenopausal (women only)&#xD;
&#xD;
          -  Healthy, as determined by medical history and laboratory tests&#xD;
&#xD;
          -  Able to complete daily bouts of walking at a moderate rate&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
          -  Body mass greater than 350 lbs. (max. weight dictated by table limit for fMRI scanner)&#xD;
             when acquisition of large bore fMRI is complete, max. wt. limit will increase to 400&#xD;
             lbs.&#xD;
&#xD;
          -  BMI less than 30.0 kg/m(2)&#xD;
&#xD;
          -  Evidence of metabolic or cardiovascular disease, or disease that may influence&#xD;
             metabolism (e.g. cancer, diabetes, thyroid disease)&#xD;
&#xD;
          -  Taking any prescription medication (except birth control) or other drug that may&#xD;
             influence metabolism (e.g. diet/weight-loss medication)&#xD;
&#xD;
          -  Hematocrit less than 34% (women only)&#xD;
&#xD;
          -  Hematocrit less than 40% (men only)&#xD;
&#xD;
          -  Pregnancy, lactation (women only)&#xD;
&#xD;
          -  Allergy to lidocaine or ethanol&#xD;
&#xD;
          -  Participating in a regular exercise program (greater than 2h/week of vigorous&#xD;
             activity)&#xD;
&#xD;
          -  Caffeine consumption greater than 150 mg/day (will be clamped at baseline intake&#xD;
             during study)&#xD;
&#xD;
          -  Regular use of alcohol (greater than 2 drinks per day), tobacco (smoking or chewing),&#xD;
             amphetamines, cocaine, heroin, or marijuana over past 6 months&#xD;
&#xD;
          -  Past or present history of eating disorder (including binge eating) or psychiatric&#xD;
             disease&#xD;
&#xD;
          -  Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, multiple food&#xD;
             allergies)&#xD;
&#xD;
          -  Are claustrophobic to a degree that they would feel uncomfortable in the MRI machine.&#xD;
&#xD;
          -  Having any metal in their body (for example, pacemakers, metallic prostheses such as&#xD;
             cochlear implants or heart valves, shrapnel fragments, etc.).&#xD;
&#xD;
          -  Left-handedness&#xD;
&#xD;
          -  Non-native English speakers&#xD;
&#xD;
          -  Volunteers unwilling or unable to give informed consent&#xD;
&#xD;
        Control Subjects&#xD;
&#xD;
        INCLUSION CRITERIA:&#xD;
&#xD;
          -  Age 18-45 years, male or female&#xD;
&#xD;
          -  18.5 kg/m(2) less than BMI less than 25.0 kg/m(2)&#xD;
&#xD;
          -  Weight stable (less than plus or minus 5 kg over past 6 months)&#xD;
&#xD;
          -  Premenopausal (women only)&#xD;
&#xD;
          -  Healthy, as determined by medical history and laboratory tests&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
          -  BMI less than 18.5 or greater than 25.0 kg/m(2)&#xD;
&#xD;
          -  Evidence of metabolic or cardiovascular disease, or disease that may influence&#xD;
             metabolism (e.g. cancer or diabetes)&#xD;
&#xD;
          -  Taking any prescription medication (except birth control) or other drug that may&#xD;
             influence metabolism (e.g. diet/weight-loss medication)&#xD;
&#xD;
          -  Hyperlipidemia (fasting plasma triglyceride concentration greater than 150 mg/dl)&#xD;
&#xD;
          -  Hematocrit less than 34% (women only)&#xD;
&#xD;
          -  Hematocrit less than 40% (men only)&#xD;
&#xD;
          -  Pregnancy, lactation (women only)&#xD;
&#xD;
          -  Participating in a regular exercise program (greater than 2h/week of vigorous&#xD;
             activity)&#xD;
&#xD;
          -  Caffeine consumption greater than 150 mg/day&#xD;
&#xD;
          -  Regular use of alcohol (greater than 2 drinks per day), tobacco (smoking or chewing),&#xD;
             amphetamines, cocaine, heroin, or marijuana over the past 6 months&#xD;
&#xD;
          -  Past or present history of eating disorder (including binge eating) or psychiatric&#xD;
             disease&#xD;
&#xD;
          -  Volunteers with strict dietary concerns (e.g vegetarian or kosher diet, multiple food&#xD;
             allergies)&#xD;
&#xD;
          -  Are claustrophobic to a degree that they would feel uncomfortable in the MRI machine.&#xD;
&#xD;
          -  Having any metal in their body (for example, pacemakers, metallic prostheses such as&#xD;
             cochlear implants or heart valves, shrapnel fragments, etc.).&#xD;
&#xD;
          -  Left-handedness&#xD;
&#xD;
          -  Non-native English speakers&#xD;
&#xD;
          -  Volunteers unwilling or unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin Hall, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_2009-DK-0081.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999 Oct 27;282(16):1523-9.</citation>
    <PMID>10546691</PMID>
  </reference>
  <reference>
    <citation>Allison DB, Zannolli R, Narayan KM. The direct health care costs of obesity in the United States. Am J Public Health. 1999 Aug;89(8):1194-9.</citation>
    <PMID>10432905</PMID>
  </reference>
  <reference>
    <citation>Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003 May 22;348(21):2074-81.</citation>
    <PMID>12761364</PMID>
  </reference>
  <results_reference>
    <citation>Hall KD, Bemis T, Brychta R, Chen KY, Courville A, Crayner EJ, Goodwin S, Guo J, Howard L, Knuth ND, Miller BV 3rd, Prado CM, Siervo M, Skarulis MC, Walter M, Walter PJ, Yannai L. Calorie for Calorie, Dietary Fat Restriction Results in More Body Fat Loss than Carbohydrate Restriction in People with Obesity. Cell Metab. 2015 Sep 1;22(3):427-36. doi: 10.1016/j.cmet.2015.07.021. Epub 2015 Aug 13.</citation>
    <PMID>26278052</PMID>
  </results_reference>
  <results_reference>
    <citation>Guo J, Simmons WK, Herscovitch P, Martin A, Hall KD. Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior. Mol Psychiatry. 2014 Oct;19(10):1078-84. doi: 10.1038/mp.2014.102. Epub 2014 Sep 9.</citation>
    <PMID>25199919</PMID>
  </results_reference>
  <results_reference>
    <citation>Simmons WK, Rapuano KM, Ingeholm JE, Avery J, Kallman S, Hall KD, Martin A. The ventral pallidum and orbitofrontal cortex support food pleasantness inferences. Brain Struct Funct. 2014 Mar;219(2):473-83. doi: 10.1007/s00429-013-0511-0. Epub 2013 Feb 9.</citation>
    <PMID>23397317</PMID>
  </results_reference>
  <results_reference>
    <citation>Simmons WK, Rapuano KM, Kallman SJ, Ingeholm JE, Miller B, Gotts SJ, Avery JA, Hall KD, Martin A. Category-specific integration of homeostatic signals in caudal but not rostral human insula. Nat Neurosci. 2013 Nov;16(11):1551-2. doi: 10.1038/nn.3535. Epub 2013 Sep 29.</citation>
    <PMID>24077565</PMID>
  </results_reference>
  <verification_date>January 22, 2020</verification_date>
  <study_first_submitted>February 14, 2009</study_first_submitted>
  <study_first_submitted_qc>February 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2009</study_first_posted>
  <results_first_submitted>October 7, 2020</results_first_submitted>
  <results_first_submitted_qc>March 1, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 24, 2021</results_first_posted>
  <last_update_submitted>March 24, 2021</last_update_submitted>
  <last_update_submitted_qc>March 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Weight Loss</keyword>
  <keyword>Carbohydrate</keyword>
  <keyword>Fat</keyword>
  <keyword>Macronutrient Balance</keyword>
  <keyword>Healthy Volunteer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fallypride</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 24, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/40/NCT00846040/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>71 participants were screened and 43 were enrolled.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Obese RF Then RC</title>
          <description>Obese adult volunteers (BMI above 30 kg/m2) randomized to receive an 85% reduction of baseline dietary fat for 2 weeks, then a 60% reduction of baseline dietary carbohydrate for 2 weeks. Each admission starts with a 5 day baseline period before the randomized diet.</description>
        </group>
        <group group_id="P2">
          <title>Obese RC Then RF</title>
          <description>Obese adult volunteers (BMI above 30 kg/m2) randomized to receive a 60% reduction of baseline dietary carbohydrate for 2 weeks, then an 85% reduction of baseline dietary fat for 2 weeks. Each admission starts with a 5 day baseline period before the randomized diet.</description>
        </group>
        <group group_id="P3">
          <title>Lean Control</title>
          <description>Lean adult volunteers (BMI below 30kg/m2) placed on a weight-maintenance diet using a standard diet composition of 50% carbohydrate, 35% fat, and 15% protein for 2 days on an out-patient basis followed by an admission to the metabolic unit for 3 days.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Baseline: Days 1-5</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>First Treatment Period: Days 6-14</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="0">This group participated in only the baseline period</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout: 2 Weeks to 10 Weeks</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Treatment: After Washout, 14 Day</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Obese RF Then RC</title>
          <description>Obese adult volunteers (BMI above 30 kg/m2) randomized to receive an 85% reduction of baseline dietary fat for 2 weeks, then a 60% reduction of baseline dietary carbohydrate for 2 weeks</description>
        </group>
        <group group_id="B2">
          <title>Obese RC Then RF</title>
          <description>Obese adult volunteers (BMI above 30 kg/m2) randomized to receive a 60% reduction of baseline dietary carbohydrate for 2 weeks, then an 85% reduction of baseline dietary fat for 2 weeks.</description>
        </group>
        <group group_id="B3">
          <title>Lean Control</title>
          <description>Lean adult volunteers (BMI below 30kg/m2) placed on a weight-maintenance diet using a standard diet composition of 50% carbohydrate, 35% fat, and 15% protein on an out-patient basis</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="23"/>
            <count group_id="B4" value="43"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.1" spread="6.9"/>
                    <measurement group_id="B2" value="35.6" spread="8.1"/>
                    <measurement group_id="B3" value="28" spread="6.2"/>
                    <measurement group_id="B4" value="31.2" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Respiratory Quotient (RQ)</title>
        <description>Respiratory quotient was calculated as the ratio of carbon dioxide production to oxygen consumption as measured in a metabolic chamber for at least 23 continuous hours on days 2 and 5 of the baseline diet and days 1, 4, and 6 of the reduced-energy diets.</description>
        <time_frame>Baseline and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RC Diet</title>
            <description>Reduced carbohydrate diet</description>
          </group>
          <group group_id="O2">
            <title>RF Diet</title>
            <description>Reduced fat diet</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Respiratory Quotient (RQ)</title>
          <description>Respiratory quotient was calculated as the ratio of carbon dioxide production to oxygen consumption as measured in a metabolic chamber for at least 23 continuous hours on days 2 and 5 of the baseline diet and days 1, 4, and 6 of the reduced-energy diets.</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0552" spread="0.003"/>
                    <measurement group_id="O2" value="0.00453" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in 24 Hour Energy Expenditure</title>
        <description>24 hour energy expenditure was measured in a respiratory chamber.</description>
        <time_frame>Baseline and 14 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RC Diet</title>
            <description>Reduced carbohydrate diet</description>
          </group>
          <group group_id="O2">
            <title>RF Diet</title>
            <description>Reduced fat diet</description>
          </group>
        </group_list>
        <measure>
          <title>Change in 24 Hour Energy Expenditure</title>
          <description>24 hour energy expenditure was measured in a respiratory chamber.</description>
          <units>kcal/day</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-97.7" spread="23"/>
                    <measurement group_id="O2" value="-49.6" spread="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Cumulative Fat Imbalance</title>
        <description>Measured as the difference between dietary fat intake and fat oxidation by the body as measured in the respiratory chamber</description>
        <time_frame>Baseline and 14 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RC Diet</title>
            <description>Reduced carbohydrate diet</description>
          </group>
          <group group_id="O2">
            <title>RF Diet</title>
            <description>Reduced fat diet</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Cumulative Fat Imbalance</title>
          <description>Measured as the difference between dietary fat intake and fat oxidation by the body as measured in the respiratory chamber</description>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-245" spread="21"/>
                    <measurement group_id="O2" value="-463" spread="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Caudate Dopamine D2-like Receptor Binding Potential (D2BP)</title>
        <description>The time-activity curves for [18F]fallypride tracer concentration in the ROIs were measured by PET and kinetic parameters were fit to a four compartment mathematical model (with the cerebellum used as the reference tissue). D2BP was expressed as the dimensionless ratio of rate constants quantifying binding and unbinding of tracer in the regions of interest.</description>
        <time_frame>Day 2 of in-patient admission</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Obese</title>
            <description>Obese adult volunteers (BMI above 30 kg/m2)</description>
          </group>
          <group group_id="O2">
            <title>Lean Control</title>
            <description>Lean adult volunteers (BMI below 30kg/m2)</description>
          </group>
        </group_list>
        <measure>
          <title>Caudate Dopamine D2-like Receptor Binding Potential (D2BP)</title>
          <description>The time-activity curves for [18F]fallypride tracer concentration in the ROIs were measured by PET and kinetic parameters were fit to a four compartment mathematical model (with the cerebellum used as the reference tissue). D2BP was expressed as the dimensionless ratio of rate constants quantifying binding and unbinding of tracer in the regions of interest.</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.2" lower_limit="26.48" upper_limit="29.86"/>
                    <measurement group_id="O2" value="24.9" lower_limit="22.95" upper_limit="26.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Putamen Dopamine D2-like Receptor Binding Potential (D2BP)</title>
        <description>The time-activity curves for [18F]fallypride tracer concentration in the ROIs were measured by PET and kinetic parameters were fit to a four compartment mathematical model (with the cerebellum used as the reference tissue). D2BP was expressed as the dimensionless ratio of rate constants quantifying binding and unbinding of tracer in the regions of interest.</description>
        <time_frame>Day 2 of in-patient admission</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Obese</title>
            <description>Obese adult volunteers (BMI above 30 kg/m2)</description>
          </group>
          <group group_id="O2">
            <title>Lean Control</title>
            <description>Lean adult volunteers (BMI below 30kg/m2)</description>
          </group>
        </group_list>
        <measure>
          <title>Putamen Dopamine D2-like Receptor Binding Potential (D2BP)</title>
          <description>The time-activity curves for [18F]fallypride tracer concentration in the ROIs were measured by PET and kinetic parameters were fit to a four compartment mathematical model (with the cerebellum used as the reference tissue). D2BP was expressed as the dimensionless ratio of rate constants quantifying binding and unbinding of tracer in the regions of interest.</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.7" lower_limit="28.61" upper_limit="32.7"/>
                    <measurement group_id="O2" value="27" lower_limit="25.14" upper_limit="28.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Accumbens Dopamine D2-like Receptor Binding Potential (D2BP)</title>
        <description>The time-activity curves for [18F]fallypride tracer concentration in the ROIs were measured by PET and kinetic parameters were fit to a four compartment mathematical model (with the cerebellum used as the reference tissue). D2BP was expressed as the dimensionless ratio of rate constants quantifying binding and unbinding of tracer in the regions of interest.</description>
        <time_frame>Day 2 of in-patient admission</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Obese</title>
            <description>Obese adult volunteers (BMI above 30 kg/m2)</description>
          </group>
          <group group_id="O2">
            <title>Lean Control</title>
            <description>Lean adult volunteers (BMI below 30kg/m2)</description>
          </group>
        </group_list>
        <measure>
          <title>Accumbens Dopamine D2-like Receptor Binding Potential (D2BP)</title>
          <description>The time-activity curves for [18F]fallypride tracer concentration in the ROIs were measured by PET and kinetic parameters were fit to a four compartment mathematical model (with the cerebellum used as the reference tissue). D2BP was expressed as the dimensionless ratio of rate constants quantifying binding and unbinding of tracer in the regions of interest.</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.3" lower_limit="16.6" upper_limit="19.94"/>
                    <measurement group_id="O2" value="16.7" lower_limit="14.16" upper_limit="19.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 12 weeks after the second in-patient visit</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Obese Reduced Carbohydrate</title>
          <description>Reduced carbohydrate diet (selective reduction of 60% of baseline carbohydrate calories per day)</description>
        </group>
        <group group_id="E2">
          <title>Obese Reduced Fat</title>
          <description>Reduced fat diet (selective reduction of 85% of baseline fat calories per day)</description>
        </group>
        <group group_id="E3">
          <title>Lean Control</title>
          <description>Lean adult volunteers (BMI below 30kg/m2) placed on a weight-maintenance diet using a standard diet composition of 50% carbohydrate, 35% fat, and 15% protein on an out-patient basis</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kevin Hall, PhD</name_or_title>
      <organization>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</organization>
      <phone>3014028248</phone>
      <email>kevinh@niddk.nih.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

